M MLTX
MoonLake Immunotherapeutics - Class A
$18.98
-1.09% ($0.21)
Volume
811,150
52W High
$62.75
52W Low
$5.95
Market Cap
$1.24B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.93
Whisper EPS
-$0.93
0.1% above consensus
Last Quarter
-$0.98
Current Streak
2 Misss
Avg Surprise (4Q)
-2.35%
Next Earnings Report
Reports in 47 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 11, 2026
1-Day:
-3.45%
Q1 2026
Mar 31, 2026
1-Day:
-11.37%
Q4 2025
Feb 26, 2026
1-Day:
-0.96%
5-Day:
+0.06%
Q4 2025
Feb 25, 2026
1-Day:
-2.96%
5-Day:
-2.96%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'24 | $101,850 | -- | 50.0% | -10,000.0% | -$45.6M |
| Q1'24 | $19,738 | -- | -115.6% | -10,000.0% | -$13.7M |
| Q4'23 | $19,738 | -- | 83.3% | -10,000.0% | -$7.4M |
Company Information
Symbol
MLTX
Company
MoonLake Immunotherapeutics - Class A
Market Cap
$1.24B
Next Earnings
Aug 4, 2026